DANIEL SAM ACIERTO: Open Payments
NPI 1528670866 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 31 payments from 12 companies in 2025. Trend: 2023 $1,875 · 2024 $2,169 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $299 |
| ABBVIE INC. | 2 | $159 |
| Dexcom, Inc. | 1 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $141 |
| Lilly USA, LLC | 3 | $137 |
| Abbott Laboratories | 1 | $121 |
| Janssen Biotech, Inc. | 1 | $108 |
| Janssen Pharmaceuticals, Inc | 3 | $92 |
| Amgen Inc. | 4 | $73 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: CAPLYTA, QULIPTA, Dexcom G6 Transmitter, Kerendia, FREESTYLE LIBRE 3, TREMFYA, SPRAVATO, OTEZLA.
Industry payments across NV — which companies pay providers there.
